Tokyo - Delayed Quote JPY
PeptiDream Inc. (4587.T)
1,888.50
-28.00
(-1.46%)
As of 9:54:01 AM GMT+9. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in JPY | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 8 | 9 |
| Avg. Estimate | 5.17B | 14.22B | 46.15B | 46.45B |
| Low Estimate | 5.17B | 14.22B | 35B | 37.9B |
| High Estimate | 5.17B | 14.22B | 50.5B | 53.3B |
| Year Ago Sales | 4.22B | 31.91B | 46.68B | 46.15B |
| Sales Growth (year/est) | 22.37% | -55.43% | -1.13% | 0.66% |
Earnings History
| Currency in JPY | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 21.56 | 147.75 | 6.35 | -4.17 |
| EPS Actual | -6.5 | 144.8 | -2.35 | -20.1 |
| Difference | -28.06 | -2.95 | -8.7 | -15.93 |
| Surprise % | -130.16% | -2.00% | -137.02% | -381.84% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4587.T | -- | -- | -- | -- |
| S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Related Tickers
4565.T Nxera Pharma Co., Ltd.
854.00
-2.51%
FYB.DE Formycon AG
24.35
-0.81%
BSLN.SW Basilea Pharmaceutica AG
44.40
+0.34%
RNTX Rein Therapeutics Inc.
1.7600
+1.15%
PHVS Pharvaris N.V.
16.99
-0.29%
KLRS Kalaris Therapeutics, Inc.
3.4800
-9.61%
NBTX Nanobiotix S.A.
3.4100
+1.49%
DSGN Design Therapeutics, Inc.
3.5000
-0.57%
ZURA Zura Bio Limited
1.2100
-3.97%
CGEM Cullinan Therapeutics, Inc.
7.54
-2.96%